1 Introduction Fetal arrhythmias occur in about 1% of pregnancies and sotalol, a beta-blocker, is one of the proposed first choice therapeutic options [1, 2]. The variety of sotalol dosing regimens for fetal tachycardia is based on scarce evidence. Only a few studies have been performed, with relatively small numbers of participants, but all studies show that only part of the group receiving sotalol is responsive to the therapy [3-6].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile